Safety and cardiovascular effects of multiple‐dose administration of aripiprazole and olanzapine in a randomised clinical trial - Koller - 2021 - Human Psychopharmacology: Clinical and Experimental - Wiley Online Library

A Randomized, Open-Label, Multiple-Dose, Parallel-Arm, Pivotal Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Aripiprazole 2-Month Long-Acting Injectable in Adults With Schizophrenia or Bipolar I Disorder

Classics in Chemical Neuroscience: Ketamine

Pharmacology and Therapeutic Potential of the 5-HT7 Receptor

Synthesis and Characterization of 5-(2-Fluoro-4-[11C]methoxyphenyl)-2,2-dimethyl-3,4-dihydro-2H-pyrano[2,3-b]pyridine-7-carboxamide as a PET Imaging Ligand for Metabotropic Glutamate Receptor 2

A Randomized, Open-Label, Multiple-Dose, Parallel-Arm, Pivotal Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Aripiprazole 2-Month Long-Acting Injectable in Adults With Schizophrenia or Bipolar I Disorder

Beyond 52-Week Long-Term Safety: Long-Term Outcomes of Aripiprazole Lauroxil for Patients With Schizophrenia Continuing in an Extension Study

The impact of adjunctive aripiprazole on QT interval: A 12‐week open label study in patients on olanzapine, clozapine or risperidone - Pilunthanakul - 2023 - Human Psychopharmacology: Clinical and Experimental - Wiley Online Library

Alimentary Pharmacology & Therapeutics, Pharmacology Journal

Schizophrenia and Related Psychoses - Major Reference Works - Wiley Online Library

Safety and cardiovascular effects of multiple‐dose administration of aripiprazole and olanzapine in a randomised clinical trial - Koller - 2021 - Human Psychopharmacology: Clinical and Experimental - Wiley Online Library

PDF) Efficacy and Comparative Effectiveness of Off-Label Use of Atypical Antipsychotics

Review of Pharmacological Treatment in Mood Disorders and Future Directions for Drug Development

Cardiometabolic Adverse Effects and Its Predictors in Children and Adolescents With First-Episode Psychosis During Treatment With Quetiapine-Extended Release Versus Aripiprazole: 12-Week Results From the Tolerance and Effect of Antipsychotics in